Composition and Specifications Peptide Breakdown GHK-Cu: 50mg TB-500: 10mg BPC-157: 10mg KPV: 10mg Total Content: 80mg Purity: 99% Form: Lyophilized powder blend Container: Sterile 3mL vial Reconstitution Requirement This product needs to be reconstituted with a sterile laboratory solvent (bacteriostatic water, or other tested and valid lab solvents) in an appropriate laboratory
This interaction was mapped at the hydrophobic domain of G0S2 and the patatin-like domain of PNPLA2, whereby overexpression of G0S2 diminished adipocyte lipolysis, and deletion increased both basal and stimulated lipolysis (52)
Overall, the pharmacokinetic parameters found in this study support once-weekly dosing of cagrilintide in combination with semaglutide 2.4 mg
Keep away from children and pets
The amount of water you add does not change the total amount of medicine in the vial, but it does change how much liquid you need to inject
The peptide arrives as lyophilised powder and must be reconstituted with bacteriostatic watertypically 2mL of bacteriostatic water added to a 5mg vial yields a concentration of 2.5mg/mL, allowing precise measurement with insulin syringes
